We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRGO icon
776
Perrigo
PRGO
$1.4B
$578K 0.02%
+3,738
New +$590K
SPH icon
777
Suburban Propane Partners
SPH
$1.24B
$578K 0.02%
13,932
+758
+6% +$33.2K
JKHY icon
778
Jack Henry & Associates
JKHY
$10.9B
$574K 0.02%
10,294
-25
-0.2% -$1.43K
BRW
779
Saba Capital Income & Opportunities Fund
BRW
$336M
$569K 0.02%
49,046
-5,279
-10% -$61.7K
GHI
780
DELISTED
GLOBAL HIGH INCOME FUND INC.
GHI
$569K 0.02%
57,643
RKT
781
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$566K 0.02%
10,720
+330
+3% +$17.3K
MUNI icon
782
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.06B
$563K 0.02%
10,700
+700
+7% +$36.8K
XLB icon
783
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$561K 0.02%
23,732
+11,438
+93% +$263K
MACK
784
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$561K 0.02%
+14,139
New +$605K
ARI
785
Apollo Commercial Real Estate
ARI
$867M
$558K 0.02%
33,526
-1,500
-4% -$25K
AEGN
786
DELISTED
Aegion Corp
AEGN
$557K 0.02%
22,000
+9,000
+69% +$199K
ALU
787
DELISTED
Alcatel-Lucent
ALU
$554K 0.02%
142,112
+84,885
+148% +$352K
CAR icon
788
Avis
CAR
$4.86B
$553K 0.02%
11,350
EW icon
789
Edwards Lifesciences
EW
$49.6B
$552K 0.02%
44,670
-32,946
-42% -$380K
SURE icon
790
AdvisorShares Insider Advantage ETF
SURE
$56.6M
$544K 0.02%
10,955
+2,796
+34% +$135K
TNL icon
791
Travel + Leisure Co
TNL
$4.66B
$544K 0.02%
16,488
+2,115
+15% +$69K
RLH
792
DELISTED
Red Lions Hotel Corporation
RLH
$544K 0.02%
93,300
DPD
793
DELISTED
DOW 30 PREMIUM & DIVIDEND INCOME FUND INC
DPD
$544K 0.02%
33,964
-5,787
-15% -$89.5K
CRNT icon
794
Ceragon Networks
CRNT
$197M
$543K 0.02%
192,200
+82,200
+75% +$262K
FWLT
795
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
$541K 0.02%
16,679
-8,100
-33% -$253K
SRF
796
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$540K 0.02%
5,861
+28
+0.5% +$2.51K
SRE icon
797
Sempra
SRE
$57.9B
$538K 0.02%
11,122
+268
+2% +$12.5K
VO icon
798
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$537K 0.02%
18,924
-2,000
-10% -$55.5K
PMT
799
PennyMac Mortgage Investment
PMT
$822M
$534K 0.02%
22,346
+4,513
+25% +$107K
BIDU icon
800
Baidu
BIDU
$37.7B
$533K 0.02%
3,493
+191
+6% +$31.9K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.